TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/23/24 20:05 | 8/23/24 | APGE | Apogee Therapeutics, Inc. | Health | BioPrd | Biological Products, (No Diag | Henderson Jane | MA | O | CFO | S | -290 | 48.26 | 0 | -6 | -3 | 201 | D | |||||||||||||||
6/21/23 17:47 | 6/16/23 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Henderson Jane | CA | D | S.d | -2,167 | 54.17 | 0 | -40 | -100 | 0 | D | |||||||||||||||
3/26/18 16:02 | 3/22/18 | VYGR | Voyager Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Henderson Jane | MA | O | SVP,CFO, | S.dm | -649 | 20.87 | 0 | -31 | -100 | 0 | D | ||||||||||||||
3/20/18 17:43 | 3/16/18 | VYGR | Voyager Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Henderson Jane | MA | O | CFO,SVP, | S.dm | -383 | 22.11 | 0 | -17 | -100 | 0 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |